Illumina and Pacific Biosciences Call Off $1.2 Billion Deal
A technician looks at a monitor for an Illumina Inc. DNA sequencing machine inside the Plasma Nucleic Acids laboratory in the Li Ka Shing Institute of Health Sciences at the Chinese University of Hong Kong in Hong Kong, China. (Photographer: Anthony Kwan/Bloomberg)

Illumina and Pacific Biosciences Call Off $1.2 Billion Deal

(Bloomberg) -- Illumina Inc. and Pacific Biosciences of California Inc. called off their planned $1.2 billion deal after U.S. antitrust enforcers last month moved to block the merger of the DNA-seq...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.